Organizer/Speaker

Karin de Visser is group leader in the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute (NKI) in Amsterdam and Oncode Institute, and a full professor of Experimental Immunobiology of Cancer at Leiden University Medical Center. She obtained her PhD in 2002 at the NKI in the field of cancer immunotherapy. During her postdoctoral research with Prof. Lisa Coussens at UCSF (2003-2005), she expanded her expertise into the field of inflammation and cancer. In 2005, she returned to the NKI and joined the lab of Prof. Jos Jonkers to gain experience with conditional mouse models of breast cancer before establishing her own research group. Her lab investigates how the immune system influences breast cancer metastasis and therapy response. Karin de Visser received an ERC consolidator grant (2014), the Metastasis Research Prize of the Beug Foundation (2015), an NWO-VICI grant (2019), the Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award (2025), the Josephine Nefkens Award (2025), and she is an elected EMBO member (2021). She co-leads the Immunotherapy research theme at the NKI.

« Go Back